BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12369898)

  • 1. Structural biology of the cell adhesion protein CD2: alternatively folded states and structure-function relation.
    Yang JJ; Ye Y; Carroll A; Yang W; Lee HW
    Curr Protein Pept Sci; 2001 Mar; 2(1):1-17. PubMed ID: 12369898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells.
    van der Merwe PA; McNamee PN; Davies EA; Barclay AN; Davis SJ
    Curr Biol; 1995 Jan; 5(1):74-84. PubMed ID: 7697352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of conformational adjustments and long-range electrostatic forces to the CD2/CD58 interaction.
    Kearney A; Avramovic A; Castro MA; Carmo AM; Davis SJ; van der Merwe PA
    J Biol Chem; 2007 May; 282(18):13160-6. PubMed ID: 17344209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure and binding properties of the CD2 and CD244 (2B4)-binding protein, CD48.
    Evans EJ; Castro MA; O'Brien R; Kearney A; Walsh H; Sparks LM; Tucknott MG; Davies EA; Carmo AM; van der Merwe PA; Stuart DI; Jones EY; Ladbury JE; Ikemizu S; Davis SJ
    J Biol Chem; 2006 Sep; 281(39):29309-20. PubMed ID: 16803907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural biology of the cell adhesion protein CD2: from molecular recognition to protein folding and design.
    Wilkins AL; Yang W; Yang JJ
    Curr Protein Pept Sci; 2003 Oct; 4(5):367-73. PubMed ID: 14529530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between human CD2 and CD58 involves the major beta sheet surface of each of their respective adhesion domains.
    Arulanandam AR; Kister A; McGregor MJ; Wyss DF; Wagner G; Reinherz EL
    J Exp Med; 1994 Nov; 180(5):1861-71. PubMed ID: 7525842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-A resolution.
    Ikemizu S; Sparks LM; van der Merwe PA; Harlos K; Stuart DI; Jones EY; Davis SJ
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4289-94. PubMed ID: 10200255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of pK(a) values of carboxyl groups in the N-terminal domain of rat CD2: anomalous pK(a) of a glutamate on the ligand-binding surface.
    Chen HA; Pfuhl M; McAlister MS; Driscoll PC
    Biochemistry; 2000 Jun; 39(23):6814-24. PubMed ID: 10841761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59.
    van der Merwe PA; Barclay AN; Mason DW; Davies EA; Morgan BP; Tone M; Krishnam AK; Ianelli C; Davis SJ
    Biochemistry; 1994 Aug; 33(33):10149-60. PubMed ID: 7520278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure and ligand interactions of CD2: implications for T-cell function.
    Davis SJ; van der Merwe PA
    Immunol Today; 1996 Apr; 17(4):177-87. PubMed ID: 8871350
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors.
    Wang JH; Smolyar A; Tan K; Liu JH; Kim M; Sun ZY; Wagner G; Reinherz EL
    Cell; 1999 Jun; 97(6):791-803. PubMed ID: 10380930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression by co-stimulatory molecules: inhibition of CD2-CD48/CD58 interaction by peptides from CD2 to suppress progression of collagen-induced arthritis in mice.
    Gokhale A; Kanthala S; Latendresse J; Taneja V; Satyanarayanajois S
    Chem Biol Drug Des; 2013 Jul; 82(1):106-18. PubMed ID: 23530775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.
    Arulanandam AR; Moingeon P; Concino MF; Recny MA; Kato K; Yagita H; Koyasu S; Reinherz EL
    J Exp Med; 1993 May; 177(5):1439-50. PubMed ID: 7683037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of a novel calcium-binding site adjacent to the ligand-binding site on CD2 increases its CD48 affinity.
    Jones LM; Yang W; Maniccia AW; Harrison A; van der Merwe PA; Yang JJ
    Protein Sci; 2008 Mar; 17(3):439-49. PubMed ID: 18287277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the glycosylated adhesion domain of human T lymphocyte glycoprotein CD2.
    Withka JM; Wyss DF; Wagner G; Arulanandam AR; Reinherz EL; Recny MA
    Structure; 1993 Sep; 1(1):69-81. PubMed ID: 7915183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating cyclic peptides inhibiting CD2-CD58 interactions through molecular dynamics and molecular docking methods.
    Leherte L; Petit A; Jacquemin D; Vercauteren DP; Laurent AD
    J Comput Aided Mol Des; 2018 Nov; 32(11):1295-1313. PubMed ID: 30368623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2.
    Somoza C; Driscoll PC; Cyster JG; Williams AF
    J Exp Med; 1993 Aug; 178(2):549-58. PubMed ID: 7688025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC'C" face of the human CD2 adhesion domain.
    Arulanandam AR; Withka JM; Wyss DF; Wagner G; Kister A; Pallai P; Recny MA; Reinherz EL
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11613-7. PubMed ID: 7505442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the low affinity interaction between rat cell adhesion molecules CD2 and CD48 by analytical ultracentrifugation.
    Silkowski H; Davis SJ; Barclay AN; Rowe AJ; Harding SE; Byron O
    Eur Biophys J; 1997; 25(5-6):455-62. PubMed ID: 9188168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cis interactions between CD2 and its ligands on T cells are required for T cell activation.
    Li B; Lu Y; Zhong MC; Qian J; Li R; Davidson D; Tang Z; Zhu K; Argenty J; de Peredo AG; Malissen B; Roncagalli R; Veillette A
    Sci Immunol; 2022 Aug; 7(74):eabn6373. PubMed ID: 35930657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.